Scientists discover that SARS-CoV-2 spike protein remains in the brain and skull bone marrow for years post-infection, ...

Researchers have discovered that the SARS-CoV-2 spike protein persists in the brain and skull bone marrow for years after ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

This work reveals how the SARS-CoV-2 spike protein’s membrane-binding domain facilitates viral entry by bridging the viral and host cell membranes. It highlights the role of a specific peptide ...

The holy grail of pandemic preparedness is being able to predict how a virus will evolve just by looking at its genetic ...

Institut de Ciència de Materials de Barcelona (ICMAB-CSIC), Campus de la UAB, E-08193 Bellaterra, Spain ...

Pfizer and BioNTech have started a mid-stage trial of a new version of the COVID-19 vaccine based on a version of the spike protein ... protection against SARS-CoV-2 variants.

Coronavirus Disease 2019 (SARS-CoV-2) vaccine is under clinical development by Shionogi and currently in Phase III for Coronavirus Disease 2019 (COVID-19).

Speculation about the alleged findings of a study on long COVID and post-vaccination syndrome spread widely among vaccine ...